Here is the latest shareholding Pattern of IPCA LABS. For more details, see the IPCA LABS financial fact sheet and IPCA LABS share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-21 |
3
Jun-21 |
3
Sep-21 |
3
Dec-21 |
3
Mar-22 |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 46.29 | 46.29 | 46.29 | 46.29 | 46.29 | 46.29 | 46.29 | 46.29 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 46.29 | 46.29 | 46.29 | 46.29 | 46.29 | 46.29 | 46.29 | 46.29 | |
Mutual Funds | % | 20.85 | 21.49 | 21.82 | 26.05 | 28.20 | 29.41 | 29.71 | 29.79 | |
Financial institution/Banks/Insurance | % | 3.64 | 3.36 | 3.18 | 3.68 | 4.20 | 3.90 | 3.57 | 3.76 | |
Government | % | 0.28 | 0.22 | 0.22 | 0.24 | 0.24 | 0.24 | 0.00 | 0.00 | |
FII | % | 17.47 | 17.81 | 18.46 | 12.34 | 11.02 | 10.61 | 10.55 | 10.44 | |
Other | % | 0.33 | 0.27 | 0.24 | 0.29 | 0.30 | 0.18 | 0.52 | 0.50 | |
Total Institution | % | 42.57 | 43.15 | 43.92 | 42.60 | 43.96 | 44.34 | 44.35 | 44.49 | |
Bodies Corporate | % | 0.75 | 0.75 | 0.72 | 1.17 | 0.50 | 0.51 | 0.47 | 0.45 | |
Individuals | % | 8.74 | 8.25 | 7.61 | 7.75 | 7.79 | 7.50 | 7.44 | 7.41 | |
NRIs/OCBs | % | 0.63 | 0.57 | 0.54 | 0.58 | 0.60 | 0.58 | 0.57 | 0.57 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 1.02 | 1.00 | 0.93 | 1.61 | 0.86 | 0.78 | 0.87 | 0.79 | |
Total Non-Institution | % | 11.14 | 10.57 | 9.80 | 11.11 | 9.75 | 9.37 | 9.35 | 9.22 | |
Total Public | % | 54.00 | 54.00 | 54.00 | 54.00 | 54.00 | 54.00 | 54.00 | 54.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
![]() |
More Pharmaceuticals Company Shareholding Pattern: PIRAMAL ENTERPRISES ZYDUS LIFESCIENCES AUROBINDO PHARMA CIPLA LUPIN
After opening the day on a positive note, Indian share markets continued their momentum and extended gains as the session progressed to end higher.